People · Operator
Named in public records as an officer, director or promoter · active 2007–2021 · Pharmaceuticals, Other Energy, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Auspex Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $82.8M | $951.9M | 2007 |
| ARS Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $63.0M | $1.3B | 2018 |
| Super Green Biofuels Inc | — | Other Energy | Series B | $40.8M | $59.7M | 2011 |
| Cns Therapeutics Inc | — | Pharmaceuticals | Series A | $13.1M | $94.5M | 2009 |
| Altair Therapeutics, Inc. | — | Biotechnology | Series A | $6.5M | $233.8M | 2009 |
Pratik Shah at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Pratik Shah on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Leff | 1 | 11 |
| Nina Kjellson | 1 | 11 |
| Michael Grey | 1 | 10 |
| John Foster | 1 | 10 |
| David Collier | 1 | 8 |
| Peter Kolchinsky | 1 | 8 |
| Rajeev Dadoo | 1 | 7 |
| Jason Brown | 1 | 7 |
| Ivor Royston | 1 | 7 |
| Kim Kamdar | 1 | 6 |
| Peter McNerney | 1 | 6 |
| Joel Martin | 1 | 5 |
| Brent Saunders | 1 | 5 |
| Howard Rosen | 1 | 5 |
| David Shapiro | 1 | 4 |
| Arama Kukutai | 1 | 4 |
| Samuel Saks | 1 | 3 |
| Nathan Wood | 1 | 3 |
| Richard Lowenthal | 1 | 2 |
| Randy Work | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.